EFFECTS OF CYTOKINES ON THE CONTRACTILITY OF CULTURED CARDIAC MYOCYTES

被引:80
作者
WEISENSEE, D
BEREITERHAHN, J
SCHOEPPE, W
LOWFRIEDRICH, I
机构
[1] UNIV FRANKFURT,CINEMAT CELL RES GRP,W-6000 FRANKFURT,GERMANY
[2] UNIV HOSP FRANKFURT,CTR INTERNAL MED,D-60590 FRANKFURT,GERMANY
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1993年 / 15卷 / 05期
关键词
D O I
10.1016/0192-0561(93)90075-A
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiac impairment is a major complication in immunotherapy. In order to investigate whether the cardiac complications are due to directly cardiodepressant cytokine effects, the contractility of heart cells in culture under immune mediator exposition was studied. The beat frequency and inotropy of spontaneously contracting cultured cardiac myocytes was determined in a microscope perfusion system equipped with computer image analysis devices. Under control conditions, the perfused cardiac myocytes were rhythmically and synchronously beating for many hours. Perfusion with the cytokines (IL-1, IL-2, IL-3, TNF) induced arrhythmias resulting in a complete cessation of spontaneous contractions and a severe loss of myocyte inotropy. The effects were concentration-dependent and reversible. Our results indicate a direct toxic interference of the interleukins and TNF with the contractile function of cultured cardiac myocytes.
引用
收藏
页码:581 / 587
页数:7
相关论文
共 20 条
[1]  
BECK AC, 1991, WESTERN J MED, V155, P293
[2]   PULMONARY-EDEMA AS A COMPLICATION OF INTERLEUKIN-2 THERAPY [J].
CONANT, EF ;
FOX, KR ;
MILLER, WT .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1989, 152 (04) :749-752
[3]   TUMOR-NECROSIS-FACTOR AND CARDIAC-FUNCTION [J].
DEMEULES, JE ;
PIGULA, FA ;
MUELLER, M ;
RAYMOND, SJ ;
GAMELLI, RL .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1992, 32 (06) :686-692
[4]  
FIEHLE M, 1991, EUR J CELL BIOL S32, V54, P81
[5]   TUMOR-NECROSIS-FACTOR-ALPHA CAUSES MYOCARDIAL DEPRESSION IN GUINEA-PIGS [J].
HEARD, SO ;
PERKINS, MW ;
FINK, MP .
CRITICAL CARE MEDICINE, 1992, 20 (04) :523-527
[6]  
KRAGEL AH, 1990, CANCER, V66, P1513, DOI 10.1002/1097-0142(19901001)66:7<1513::AID-CNCR2820660713>3.0.CO
[7]  
2-X
[8]   INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF SOLID TUMORS - ANALYSIS OF TOXICITY AND MANAGEMENT GUIDELINES [J].
MARGOLIN, KA ;
RAYNER, AA ;
HAWKINS, MJ ;
ATKINS, MB ;
DUTCHER, JP ;
FISHER, RI ;
WEISS, GR ;
DOROSHOW, JH ;
JAFFE, HS ;
ROPER, M ;
PARKINSON, DR ;
WIERNIK, PH ;
CREEKMORE, SP ;
BOLDT, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :486-498
[9]   ENDOTOXIN AND TUMOR NECROSIS FACTOR CHALLENGES IN DOGS SIMULATE THE CARDIOVASCULAR PROFILE OF HUMAN SEPTIC SHOCK [J].
NATANSON, C ;
EICHENHOLZ, PW ;
DANNER, RL ;
EICHACKER, PQ ;
HOFFMAN, WD ;
KUO, GC ;
BANKS, SM ;
MACVITTIE, TJ ;
PARRILLO, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) :823-832
[10]   MYOCARDIAL TOXIC EFFECTS DURING RECOMBINANT INTERLEUKIN-2 THERAPY [J].
NORA, R ;
ABRAMS, JS ;
TAIT, NS ;
HIPONIA, DJ ;
SILVERMAN, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (01) :59-63